Acadia Pharmaceuticals Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $16.7M | $16.7M | $50.0K | $66.4M |
| FY2024 | $157.7M | $157.2M | $523.0K | $67.0M |
| FY2025 | $109.8M | $105.1M | $4.7M | $52.1M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $16.7M | $16.7M | $50.0K | $66.4M |
| FY2024 | $157.7M | $157.2M | $523.0K | $67.0M |
| FY2025 | $109.8M | $105.1M | $4.7M | $52.1M |